Pharmacogenetic polymorphisms of the AR and metabolism and susceptibility to hormone-induced azoospermia

Citation
B. Yu et Dj. Handelsman, Pharmacogenetic polymorphisms of the AR and metabolism and susceptibility to hormone-induced azoospermia, J CLIN END, 86(9), 2001, pp. 4406-4411
Citations number
40
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
ISSN journal
0021972X → ACNP
Volume
86
Issue
9
Year of publication
2001
Pages
4406 - 4411
Database
ISI
SICI code
0021-972X(200109)86:9<4406:PPOTAA>2.0.ZU;2-R
Abstract
Clinical trials of hormonal male contraceptive regimens have identified a c onsistent population polymorphism in susceptibility to hormone-induced azoo spermia. Using identical hormonal regimens, fewer men of European origin (a pproximately two thirds) become azoospermic compared with Asian men who vir tually all become azoospermic. This variation within and between population s remains unexplained. To investigate pharmacogenetic differences in androg en metabolism or action that might explain variable susceptibility to hormo nal. induced azoospermia, we studied single nucleotide polymorphism in the CYP3A4 gene, which encodes the major hepatic T-inactivating enzyme, and CAG and GGC triplet repeats in the AR gene in 75 Australian volunteers partici pating in a male hormonal contraceptive study and 106 population controls. These men were classified into groups according to whether 6 months of week ly T enanthate injections produced azoospermia (n = 54), near-azoospermia ( n = 7), and non-azoospermia (n = 14). Mutagenically differentiated PCR was designed to identify A/G variants in the promoter region of the CYP3A4 gene . Fluorescent-labeled DNA fragments containing either CAG or GGC repeats we re amplified from the genomic DNA, and their sizes were determined based on the capillary electrophoresis. The G allele of CYP3A4 gene was absent from the nonazoospermia and near-azoospermia groups, but overall this single nu cleotide polymorphism distribution did not differ significantly between men in the azoospermia group or population controls. There were no significant differences in distribution of CAG and GGC triplet repeats among three gro ups or between them and the population controls based on the maximum likeli hood estimate of the odds ratio and CLUMP II analyses. These results sugges ted that neither genetic polymorphisms in the AR gene (CAG and GGC repeats) nor that in hepatic androgen metabolism (CYP3A4 A/G variant) were the majo r contributors to the within-population variations in susceptibility to T-i nduced azoospermia.